Correlation Between Processa Pharmaceuticals and Scryb

Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Scryb at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Scryb into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Processa Pharmaceuticals and Scryb Inc, you can compare the effects of market volatilities on Processa Pharmaceuticals and Scryb and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Scryb. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Scryb.

Diversification Opportunities for Processa Pharmaceuticals and Scryb

0.23

Correlation Coefficient

Processa Pharmaceuticals  Scryb

Modest diversification

The 3 months correlation between Processa and Scryb is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Scryb Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scryb Inc and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Scryb. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scryb Inc has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Scryb go up and down completely randomly.

Pair Corralation between Processa Pharmaceuticals and Scryb

Given the investment horizon of 90 days Processa Pharmaceuticals is expected to generate 4.55 times less return on investment than Scryb. But when comparing it to its historical volatility, Processa Pharmaceuticals is 2.18 times less risky than Scryb. It trades about 0.04 of its potential returns per unit of risk. Scryb Inc is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  0.90  in Scryb Inc on April 28, 2025 and sell it today you would earn a total of  0.00  from holding Scryb Inc or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Processa Pharmaceuticals  vs.  Scryb Inc

Processa Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Processa Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Processa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Scryb Inc

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Scryb Inc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Scryb reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Processa Pharmaceuticals and Scryb

The main advantage of trading using opposite Processa Pharmaceuticals and Scryb positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Scryb can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scryb will offset losses from the drop in Scryb's long position.

The idea behind Processa Pharmaceuticals and Scryb Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .